Omada Health (U76) Stock Overview

Provides a range of virtual care programs in the United States. More details

U76 fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	2/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 61.2% below our estimate of its fair value

Revenue is forecast to grow 21.15% per year

Revenue grew by 47.1% over the past year

Analysts in good agreement that stock price will rise by 54.3%

Risk Analysis

Shares are highly illiquid

Currently unprofitable and not forecast to become profitable over the next 3 years

U76 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Omada Health, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Omada Health
Historical stock prices
Current Share Price	US$16.04
52 Week High	US$21.83
52 Week Low	US$15.42
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-26.51%

Recent updates

Shareholder Returns

	U76	DE Healthcare	DE Market
7D	2.8%	1.2%	3.6%
1Y	n/a	24.3%	12.2%

Return vs Industry: Insufficient data to determine how U76 performed against the German Healthcare industry.

Return vs Market: Insufficient data to determine how U76 performed against the German Market.

Price Volatility

Is U76's price volatile compared to industry and market?
U76 volatility
U76 Average Weekly Movement	n/a
Healthcare Industry Average Movement	6.5%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	12.4%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: U76's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine U76's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2011	868	Sean Duffy	www.omadahealth.com

Omada Health, Inc. provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care.

Omada Health, Inc. Fundamentals Summary

How do Omada Health's earnings and revenue compare to its market cap?
U76 fundamental statistics
Market cap	€934.39m
Earnings (TTM)	-€22.57m
Revenue (TTM)	€200.23m

4.7x

P/S Ratio

-41.4x

P/E Ratio

Is U76 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
U76 income statement (TTM)
Revenue	US$232.34m
Cost of Revenue	US$82.93m
Gross Profit	US$149.41m
Other Expenses	US$175.60m
Earnings	-US$26.19m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-0.45
Gross Margin	64.31%
Net Profit Margin	-11.27%
Debt/Equity Ratio	0%

How did U76 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/11/30 16:58
End of Day Share Price	2025/11/28 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Omada Health, Inc. is covered by 12 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Vikram Kesavabhotla	Baird
Saket Kalia	Barclays
Sean Dodge	BMO Capital Markets Equity Research

Omada Health, Inc.BST:U76 Stock Report